Q1 2023 Esperion Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome. (Operator Instructions) Please be advised that today's conference may be recorded.
I would now like to hand the conference over to Tiffany Aldrich, Associate Director, Corporate Communications, at Esperion.
Please go ahead, Tiffany.
Thank you. Good morning and welcome to Esperion's First Quarter 2023 Earnings Conference Call.
I want to remind callers that the information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in today's press release, presentation and our SEC filings. The content of this conference call contains time-sensitive information that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |